Plain-English translation of NCT07304778 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a mobile app called glUCModel that uses artificial intelligence to help people with type 1 diabetes manage their insulin doses better. The app analyzes your blood sugar data from a continuous glucose monitor and gives you personalized recommendations about how much insulin to take. The study wants to find out whether using this app alongside your regular insulin injections leads to better blood sugar control.
Managing type 1 diabetes requires constant decisions about insulin dosing based on meals, exercise, stress, and other factors — and getting it wrong can cause dangerously low or high blood sugar. This trial exists to see whether an AI tool can help make those decisions easier and more accurate, ultimately helping people avoid serious complications.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will continue taking insulin exactly as you normally do. The intervention group will also download and use the glUCModel app on your phone, which will analyze your glucose monitor data and give you dosing suggestions. The study will compare your blood sugar control data from the final two weeks of the trial between those using the app and those not using it. The trial is designed to be part of your normal diabetes management routine.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Spain